In summary, our current research exploratively discovered that ULK2 suppressed cell migration and invasion of ovarian cancer via inhibition of the insulin signaling pathway by promoting upregulation of IGFBP3. This evidence concerns the gene IGFBP3 and ovarian carcinoma.